Literature DB >> 2238090

Caffeine as a model drug of abuse.

S G Holtzman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2238090     DOI: 10.1016/0165-6147(90)90175-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  8 in total

1.  Psychosis with Vicks Formula 44-D abuse.

Authors:  D F Craig
Journal:  CMAJ       Date:  1992-04-01       Impact factor: 8.262

Review 2.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

3.  Chronic caffeine intake reverses age-induced insulin resistance in the rat: effect on skeletal muscle Glut4 transporters and AMPK activity.

Authors:  Maria P Guarino; Maria J Ribeiro; Joana F Sacramento; Sílvia V Conde
Journal:  Age (Dordr)       Date:  2012-09-14

4.  Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

Authors:  Shashank M Dravid; Kevin Erreger; Hongjie Yuan; Katherine Nicholson; Phuong Le; Polina Lyuboslavsky; Antoine Almonte; Ernest Murray; Cara Mosely; Jeremy Barber; Adam French; Robert Balster; Thomas F Murray; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

5.  Chronic caffeine exposure in adolescence promotes diurnal, biphasic mood-cycling and enhanced motivation for reward in adult mice.

Authors:  David J Hinton; Lindsey G Andres-Beck; Kelle E Nett; Alfredo Oliveros; Sun Choi; Marin Veldic; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2019-05-13       Impact factor: 3.332

Review 6.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

7.  Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Authors:  N Amin; E Byrne; J Johnson; G Chenevix-Trench; S Walter; I M Nolte; J M Vink; R Rawal; M Mangino; A Teumer; J C Keers; G Verwoert; S Baumeister; R Biffar; A Petersmann; N Dahmen; A Doering; A Isaacs; L Broer; N R Wray; G W Montgomery; D Levy; B M Psaty; V Gudnason; A Chakravarti; P Sulem; D F Gudbjartsson; L A Kiemeney; U Thorsteinsdottir; K Stefansson; F J A van Rooij; Y S Aulchenko; J J Hottenga; F R Rivadeneira; A Hofman; A G Uitterlinden; C J Hammond; S-Y Shin; A Ikram; J C M Witteman; A C J W Janssens; H Snieder; H Tiemeier; B H R Wolfenbuttel; B A Oostra; A C Heath; E Wichmann; T D Spector; H J Grabe; D I Boomsma; N G Martin; C M van Duijn
Journal:  Mol Psychiatry       Date:  2011-08-30       Impact factor: 15.992

8.  Potential activity of the purine compounds caffeine and aminophylline on bacteria.

Authors:  Ali Abdul Hussein S Al-Janabi
Journal:  J Glob Infect Dis       Date:  2011-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.